Skip to main content

Table 4 No. of patients from the different intervals that were included in the statistical analysis

From: The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine

Interval

Group size (no. of patients)

Spondylodiscitis

Controls

Pre-OP

16

20

3–5 days post-OP

14

14

6–11 days post-OP

16

19

40–56 days post-OP

12

19

63–142 days post-OP

16

19

Overall post-OP

11

12